ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Recruiting
105 enrolled
LUSIP
Not yet recruiting
477 enrolled
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
Recruiting
1,000 enrolled
LUNG-ROLL
Recruiting
60,000 enrolled
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Recruiting
700 enrolled
DeniLA
Recruiting
200 enrolled
European Real-World Registry for Use of the Ion Endoluminal System
Recruiting
1,200 enrolled
CREATE
Active not recruiting
712 enrolled
Korea Post Marketing Surveillance (PMS) Study of Vizimpro
Completed
188 enrolled
AB1MALT
Active not recruiting
35 enrolled
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
Active not recruiting
1,000 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
SHIELD
Active not recruiting
12,000 enrolled
FOREFRONT
Active not recruiting
532 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
LIST
Completed
535 enrolled
Imfinzi PMS
Completed
712 enrolled
A Multicenter Study to Evaluate the Cios Spin and the Ion Endoluminal System for Pulmonary Nodule Biopsy
Completed
155 enrolled
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Active not recruiting
5,000 enrolled
AB1MALTISC-UK
Recruiting
18 enrolled
An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
Recruiting
1,340 enrolled
TraveraRTGx
Recruiting
200 enrolled
Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
Recruiting
100 enrolled
PROACT-LUNG
Recruiting
20,000 enrolled
RECAP
Completed
1,041 enrolled
LARCS
Recruiting
512 enrolled
K-ACCELERATE
Enrolling by invitation
1,000 enrolled
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
Active not recruiting
29 enrolled
RADICAL-REACT
Recruiting
450 enrolled
START
Terminated
10 enrolled
DELFI-L201
Active not recruiting
11,935 enrolled
BioMolCTC
Recruiting
50 enrolled
LumenDx
Recruiting
300 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
RELIVE
Completed
480 enrolled
CHAMPION
Completed
290 enrolled
MYLUNG
Active not recruiting
1,002 enrolled
Collection of Sputum and Labeling for Lung Cancer
Recruiting
500 enrolled
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Recruiting
10,000 enrolled
PREFER
Completed
1,429 enrolled
TARGET
Completed
691 enrolled
DIASTAG
Not yet recruiting
3,000 enrolled
INSPIRE
Recruiting
5,350 enrolled
K-DETEK
Completed
9,057 enrolled
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
Not yet recruiting
350 enrolled
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Recruiting
250 enrolled
Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment
Completed
22,517 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn